An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Bristol-Myers Squibb

Summary

The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).

Eligibility

Age range: Not specified
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: \- Participants must have participated in either IM027068 or IM0271015 without discontinuing treatment permanently due to withdrawal of informed consent in either IM027068 or IM0271015. Exclusion Criteria: * Any disease/condition that, in the investigator's judgment, may pose an unacceptable safety risk for study participation. * Any AE that resulted in permanent discontinuation of IMP in IM027068 or IM0271015. * Exhibit symptoms of heart failure at rest. * History of lung reduction surgery or lung transplant. * Participants with known PAH (Pulmonary Arterial Hypertensio…

Locations (275)

Local Institution - 0113
Birmingham, Alabama
Local Institution - 0111
Ocala, Florida
Local Institution - 0119
Philadelphia, Pennsylvania
Local Institution - 0013
Florida, Vicente López, Buenos Aires
Local Institution - 0014
Mar del Plata, Buenos Aires
Local Institution - 0007
Quilmes, Buenos Aires

Summary

Eligibility

Interventions

Locations (275)